Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Cancer Research|November 15, 1988
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damageW T Bellamy, W S Dalton, J M Kailey, et al.
Cancer Detection and Prevention|January 1, 1988
Pharmacokinetics and metabolism of retinol administered at a chemopreventive level to normal subjectsD S Alberts, L McDonald, L Edwards, et al.
Anti-Cancer Drugs|February 1, 1994
Phase I study of adozelesin (U-73,975) in patients with solid tumorsG J Shamdas, D S Alberts, M Modiano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patientsA C Buzaid, D S Alberts, J Einspahr, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
Journal of the National Cancer Institute|June 8, 1999
Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosaM E Martínez, D Heddens, D L Earnest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemiaE J Feldman, D S Alberts, Z Arlin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trialR Calaluce, D L Earnest, D Heddens, et al.
Cancer Research|May 1, 1982
Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancerG E Goodman, J G Einspahr, D S Alberts, et al.
American Journal of Clinical Oncology|December 1, 1996
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapyA Yeilding, L Bertoli, P Eisenberg, et al.
Pageof 32